These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6490439)

  • 1. The effect of adjuvant chemotherapy on the cosmetic results after primary radiation treatment for early stage breast cancer.
    Beadle GF; Come S; Henderson IC; Silver B; Hellman S; Harris JR
    Int J Radiat Oncol Biol Phys; 1984 Nov; 10(11):2131-7. PubMed ID: 6490439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cosmetic results after surgery, chemotherapy, and radiation therapy for early breast cancer.
    Abner AL; Recht A; Vicini FA; Silver B; Hayes D; Come S; Harris JR
    Int J Radiat Oncol Biol Phys; 1991 Jul; 21(2):331-8. PubMed ID: 2061109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of sequence and type of chemotherapy and radiation therapy on cosmesis and complications after breast conservation therapy.
    Markiewicz DA; Schultz DJ; Haas JA; Harris EE; Fox KR; Glick JH; Solin LJ
    Int J Radiat Oncol Biol Phys; 1996 Jul; 35(4):661-8. PubMed ID: 8690631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 5-year results of a randomized trial of adjuvant radiation therapy after chemotherapy in breast cancer patients treated with mastectomy.
    Griem KL; Henderson IC; Gelman R; Ascoli D; Silver B; Recht A; Goodman RL; Hellman S; Harris JR
    J Clin Oncol; 1987 Oct; 5(10):1546-55. PubMed ID: 3309196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of adjuvant systemic treatment on cosmetic outcome and late normal-tissue reactions after breast conservation.
    Johansen J; Overgaard J; Overgaard M
    Acta Oncol; 2007; 46(4):525-33. PubMed ID: 17497320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of adjuvant chemotherapy with methotrexate and fluorouracil with and without cyclophosphamide in breast cancer patients with one to three positive axillary lymph nodes.
    Shapiro CL; Gelman RS; Hayes DF; Osteen R; Obando A; Canellos GP; Frei E; Henderson IC
    J Natl Cancer Inst; 1993 May; 85(10):812-7. PubMed ID: 8487326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of adjuvant chemotherapy on cosmesis and complications in patients with breast cancer treated by definitive irradiation.
    Danoff BF; Goodman RL; Glick JH; Haller DG; Pajak TF
    Int J Radiat Oncol Biol Phys; 1983 Nov; 9(11):1625-30. PubMed ID: 6417073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The presence of proliferative breast disease with atypia does not significantly influence outcome in early-stage invasive breast cancer treated with conservative surgery and radiation.
    Fowble B; Hanlon AL; Patchefsky A; Freedman G; Hoffman JP; Sigurdson ER; Goldstein LJ
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):105-15. PubMed ID: 9747827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in premenopausal women with axillary lymph node positive breast carcinoma.
    Bang SM; Heo DS; Lee KH; Byun JH; Chang HM; Noh DY; Choe KJ; Bang YJ; Kim SR; Kim NK
    Cancer; 2000 Dec; 89(12):2521-6. PubMed ID: 11135211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conservation treatment intensified with tamoxifen and CAF chemotherapy without axillary dissection for early breast cancer patients with clinically-negative axillary nodes.
    Ogawa Y; Nishioka A; Inomata T; Yokota N; Sasaki T; Terashima M; Yoshida S; Tanaka Y; Tohchika N
    Oncol Rep; 1999; 6(4):801-5. PubMed ID: 10373660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.
    Overgaard M; Hansen PS; Overgaard J; Rose C; Andersson M; Bach F; Kjaer M; Gadeberg CC; Mouridsen HT; Jensen MB; Zedeler K
    N Engl J Med; 1997 Oct; 337(14):949-55. PubMed ID: 9395428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent chemotherapy and radiation for breast conservation treatment of early-stage breast cancer.
    Markiewicz DA; Fox KR; Schultz DJ; Harris EE; Haas JA; Glick JH; Solin LJ
    Cancer J Sci Am; 1998; 4(3):185-93. PubMed ID: 9612601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy.
    Gasparini G; Toi M; Miceli R; Vermeulen PB; Dittadi R; Biganzoli E; Morabito A; Fanelli M; Gatti C; Suzuki H; Tominaga T; Dirix LY; Gion M
    Cancer J Sci Am; 1999; 5(2):101-11. PubMed ID: 10198732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
    Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying good prognosis group of breast cancer patients with 1-3 positive axillary nodes for adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF) chemotherapy.
    Lin YC; Chen SC; Chang HK; Hsueh S; Tsai CS; Lo YF; Hwang TL; Chen MF
    Jpn J Clin Oncol; 2005 Sep; 35(9):514-9. PubMed ID: 16199422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of adjuvant chemotherapy on cosmesis and complications in stages I and II carcinoma of the breast treated by biopsy and radiation therapy.
    Ray GR; Fish VJ; Marmor JB; Rogoway W; Kushlan P; Arnold C; Lee RH; Marzoni F
    Int J Radiat Oncol Biol Phys; 1984 Jun; 10(6):837-41. PubMed ID: 6429099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].
    Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
    Cancer Radiother; 2004 Jun; 8(3):155-67. PubMed ID: 15217583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Premenopausal breast cancer patients treated with conservative surgery, radiotherapy and adjuvant chemotherapy have a low risk of local failure.
    Rose MA; Henderson IC; Gelman R; Boyages J; Gore SM; Come S; Silver B; Recht A; Connolly JL; Schnitt SJ
    Int J Radiat Oncol Biol Phys; 1989 Oct; 17(4):711-7. PubMed ID: 2777660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of postoperative and primary radiation therapy on delivered dose of adjuvant cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) chemotherapy in breast cancer.
    Levine JF; Coleman CN; Cox RS; Ray GR; Rogoway WM; Martinez A; Stockdale FE
    Cancer; 1984 Jan; 53(2):237-41. PubMed ID: 6546300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B.
    Weiss RB; Woolf SH; Demakos E; Holland JF; Berry DA; Falkson G; Cirrincione CT; Robbins A; Bothun S; Henderson IC; Norton L;
    J Clin Oncol; 2003 May; 21(9):1825-35. PubMed ID: 12721260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.